DNA nanotechnology, the self-assembly of DNA into 2D and 3D nanoscale structures facilitated via Watson and Crick base pairing, provides alternative solutions for biomedical challenges, especially for therapeutic cargo delivery, because it is easily fabricated, exhibits low cytotoxicity, and high biocompatibility. However, the stability of these DNA nanostructures (DN) under cellular environment presents an issue due to their requirements for high salt conditions and susceptibility to nuclease degradation. Furthermore, DNs are typically trapped in endolysosomal compartments rather than the cytosol, where most of their cargo must be delivered. Many attempts to mitigate the stability issue have been made in recent years. Previously, our lab designed an endosomal escape peptide, Aurein 1.2 (denoted “EE, for endosomal escape)”, combined with a decalysine sequence (K10) proven to electrostatically adhere to and protect DNs under cell culture conditions. Unfortunately, this molecule, termed K10-EE, only resulted in endosomal escape in absence of serum due to formation of a protein corona on the surface of the coated DN.6 Therefore, we now propose to electrostatically coat the DN with a polymer composed of decalysine (K10), polyethylene glycol (PEG, which demonstrates antibiofouling properties), and peptide EE: K10- PEG1k-EE. Described herein are the attempted synthetic schemes of K10-PEG1k-EE, the successful synthesis of alternative products, K10-(EK)5 and K10-(PEG12)2-EE, and their resulting impacts on DN stability under biological conditions. Coating of the K10-(EK)5 with a DNA barrel origami demonstrated inefficient stabilizing capability in serum. Future studies include testing K10- (PEG12)2-EE protection for a variety of nucleic acid-based structures.

With climate change threatening to increase the frequency of global pandemics, the need for quick and adaptable responses to novel viruses will become paramount. DNA nanotechnology offers a highly customizable, biocompatible approach to combating novel outbreaks. For any DNA nanotechnology-based therapeutic to have future success in vivo, the structure must be able to withstand serological conditions for an extended time period. In this study, the stability of a wireframe DNA snub cube with attached nbGFP used to bind a nonessential viral epitope on Pseudorabies virus is evaluated in vitro both with and without one of two modifications designed to enhance stability: 1) the use of trivalent spermidine cations during thermal annealing of the nanostructure, and 2) the introduction of a polylysine-polyethylene glycol coating to the conjugated nanostructure. The design, synthesis, and purification of the multivalent inhibitor were also evaluated and optimized. Without modification, the snub cube nanostructure was stable for up to 8 hours in culture media supplemented with 10% FBS. The spermidine-annealed nanostructures demonstrated lesser degrees of stability and greater degradation than the unmodified structures, whereas the polylysine-coated structures demonstrated equivalent stability at lower valencies and enhanced stability at the highest valency of the snub cube inhibitor. These results support the potential for the polylysine-polyethylene glycol coating as a potential method for enhancing the stability of the snub cube for future in vivo applications.